OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Capital Work in Progress History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹0.23 Cr | - | - | ₹0.34 Cr | ₹0.66 Cr |
What is the latest Capital Work in Progress ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹0.23 Cr |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | ₹0.34 Cr |
| Mar2021 | ₹0.66 Cr |
How is Capital Work in Progress of OXYGENTA PHARMACEUTICAL Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.23 Cr | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | -100.00 | |
| Mar2022 | ₹0.34 Cr | -47.63 | |
| Mar2021 | ₹0.66 Cr | - | |
Compare Capital Work in Progress of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹184.5 Cr | -0.3% | -15% | -31.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -0.3% |
-15% |
-31.1% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses